# US 2006/0033224 A1 · Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0033224 A1
- Document ID: US20060033224A1
- Status: Published application
- Kind: A1
- Application number: 10/840,308
- Filed: 2004-05-06
- Published: 2006-02-16
- Earliest claimed: 2000-12-29
- Assignees: Aphios Corporation
- Inventors: Trevor Castor
- Web page: https://patentgrep.com/patent/US20060033224A1

## CPC

- A61K 9/5153: {Polyesters, e.g. poly(lactide-co-glycolide)}
- A61K 9/1694: {resulting in granules or microspheres of the matrix type containing more than 5% of excipient}
- A61K 9/5192: {Processes}
- B29B 9/12: characterised by structure or composition
- B29B 2009/125: {Micropellets, microgranules, microparticles}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B29B: PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS

## Abstract

This invention is for an improved process to formulate polymeric microspheres/nanospheres and encapsulate therapeutic proteins and other useful substances. Non-toxic supercritical or near-critical fluids with/without polar cosolvents are utilized to solubilize biodegradable polymers and form uniform polymer microspheres and nanospheres to encapsulate proteins with controlled-release characteristics.

## Claims

### Claim 1

A method of making polymeric spheres having an average diameter of between 0.01 and 10.0 microns, comprising the steps of:
a) providing a polymer solution of a polymeric material dissolved in a first fluid, said first fluid consisting of a supercritical, critical or near-critical fluid; and, b) depressurizing said polymer solution as said polymer solution exits one or more orifices in the presence of a low solubility fluid, said low solubility fluid having low volatility and said polymeric material in a concentration which exceeds said solubility of said polymeric material in said low solubility fluid, said polymeric material forming spheres having an average diameter between 0.01 and 10.0 microns and said first fluid removed during depressurization
wherein said low solubility fluid is selected from the group of solvents consisting of PVA, PBS, liquid nitrogen, distilled water and an alcohol.

### Claim 2 (depends on 1)

The method of claim 1 wherein said spheres have an average diameter of between 0.1 to 1.0 microns.

### Claim 3 (depends on 1)

The method of claim 1 wherein said polymer solution has a bioactive material, said bioactive material dissolved in said polymer solution or held in said polymer solution as a suspension or emulsion.

### Claim 4 (depends on 3)

The method of claim 3 wherein said bioactive material is dissolved in said first fluid.

### Claim 5 (depends on 3)

The method of claim 3 wherein said bioactive material is held as a suspension in said polymer solution.

### Claim 6 (depends on 3)

The method of claim 3 wherein said bioactive material is held as an emulsion in said polymeric solution.

### Claim 7 (depends on 3)

The method of claim 3 wherein said bioactive material is dissolved in a second fluid and said second is combined with said first fluid and polymeric material.

### Claim 8 (depends on 7)

The method of claim 7 wherein said second fluid is a supercritical, critical or near-critical fluid.

### Claim 9 (depends on 7)

The method of claim 7 wherein said bioactive material is held as a suspension in said second fluid.

### Claim 10 (depends on 3)

The method of claim 3 wherein said bioactive material is held as an emulsion in said second fluid.

### Claim 11 (depends on 1)

The method of claim 1 wherein said polymer solution is depressurized to ambient pressure.

### Claim 12

(canceled)

### Claim 13 (depends on 1)

The method of claim 1 wherein said polymer is selected from one or more of the group of polymers consisting of poly(L-lactic acid), poly(D, L-lactic acid), poly(glycolic acid) and carboxylic acid and ester derivatives thereof, poly(fumaric anhydride) and poly(sebacic anhydride) and derivatives thereof.

### Claim 14

A method of making polymeric spheres having an average diameter of between 0.01 and 10.0 microns, comprising the steps of:
a) providing a polymer solution of a polymeric material in a first fluid, said first fluid consisting of a supercritical, critical or near-critical fluid;
b) providing a second solution of a bioactive material in a second fluid;
c) forming an admixture of said first solution and said second solution to form a third solution, said third solution comprising a supercritical, critical or near-critical fluid;
d) depressurizing said third solution as said third solution exits one or more orifices in the presence of a low solubility fluid, said low solubility fluid having low volatility and said polymeric material in a concentration which exceeds said solubility of said polymeric material in said low solubility fluid, said polymeric material forming spheres having an average diameter of 0.01 to 10.0 microns, said spheres containing said bioactive material and said first fluid removed during depressurization
wherein said low solubility fluid is selected from the group of solvents consisting of PVA, PBS, liquid nitrogen, distilled water and an alcohol.

### Claim 15 (depends on 14)

The method of claim 14 wherein said spheres have an average diameter of between 0.1 to 1.0 microns.

### Claim 16

An apparatus for forming one or more polymeric spheres having an average diameter of between 0.01 and 10.0 microns, comprising:
a) an admixture vessel for receiving a polymer solution which polymer solution is a polymeric material dissolved in a first fluid, said first fluid consisting of a supercritical, critical or near-critical fluid;
b) an orifice nozzle in communication with said admixture vessel for receiving said polymer solution;
c) a depressurization vessel containing a low solubility fluid in communication with said orifice nozzle for receiving a stream of polymer solution as said polymer solution exits one or more orifices in the presence of said low solubility fluid, said low solubility fluid having low volatility and said polymeric material in a concentration which exceeds said solubility of said polymeric material in said low solubility fluid, said polymeric material forming spheres having an average diameter of 0.01 to 10.0 microns and said first fluid removed during depressurization
d) a polymer vessel for forming a solution of a polymer in a supercritical, critical or near critical fluid, said polymer vessel in fluid communication with said admixture vessel; and,
e) a bioactive material vessel for forming a suspension, solution or emulsion of said bioactive material in said polymer solution, said bioactive vessel in communication with said admixture vessel.

### Claim 17 (depends on 16)

The apparatus of claim 16 wherein said spheres have an average diameter of between 0.1 to 1.0 microns.

### Claim 18 (depends on 16)

The apparatus of claim 16 wherein said admixture vessel receives a bioactive material, said bioactive material dissolved in a solvent or held as a suspension in a fluid or held in an emulsion, and said bioactive material incorporated into said spheres during depressurization.

### Claim 19

(canceled)

### Claim 20

(canceled)
